MDWerks, Inc. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from ___________ to _____________ MDwerks, Inc. (Exact name of small business issuer as specified in its charter) Commission File No. 000-56299 Delaware 33-1095411 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 12 Park Mirage Lane Rancho Mirage , CA 92270 (Address of Principal Executive Offices) (403) 988-2005 (Issuer’s telephone number) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common MDWK N/A Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐     Accelerated filer ☐      Non-accelerated filer ☒    Smaller reporting company ☒      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☒ Yes ☐ No As of November 3, 2022 the Company has 18,010,208 shares of common stock issued and outstanding. Table of Contents PART I—FINANCIAL INFORMATION 4 Item 1. Financial Statements 4 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 11 Item 3. Quantitative and Qualitative Disclosures About Market Risk 14 Item 4. Controls and Procedures 14 PART II—OTHER INFORMATION 15 Item 1. Legal Proceedings 15 Item 1A. Risk Factors 15 Item 2. Unregistered Sales of Securities and Use of Proceeds 15 Item 3. Defaults Upon Senior Securities 15 Item 4. Mine Safety Disclosure 15 Item 5. Other Information 15 Item 6. Exhibits 15 SIGNATURES 16 EXHIBIT 31.1 EXHIBIT 31.2 EXHIBIT 32.1 2 Forward-Looking Statements Various statements contained in this report constitute “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are based on current expectations and are indicated by words or phrases such as “believe,” “expect,” “may,” “will,” “should,” “seek,” “plan,” “intend” or “anticipate” or the negative thereof or comparable terminology, or by discussion of strategy. Forward-looking statements represent as of the date of this report our judgment relating to, among other things, future results of operations, growth plans, sales, capital requirements and general industry and business conditions applicable to us. Such forward-looking statements are based largely on our current expectations and are inherently subject to risks and uncertainties. Our actual results could differ materially from those that are anticipated or projected as a result of certain risks and uncertainties, including, but not limited to, a number of factors, such as: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles and the other risks and uncertainties that are set forth in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These factors are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors could also have material adverse effects on future results. Except as otherwise required to be disclosed in periodic reports required to be filed by public companies with the Securities and Exchange Commission (“SEC”) pursuant to the SEC’s rules, we have no duty to update these statements, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks and uncertainties, we cannot assure you that the forward-looking information contained in this report will in fact transpire. As used in this Quarterly Report on Form 10-Q, unless the context requires or is otherwise indicated, the terms “we,” “us,” “our,” the “Registrant,” the “Company,” “our company” and similar expressions means MDwerks, Inc. 3 Item 1. Financial Statements MDWERKS, INC. Condensed Balance Sheets September 30, 2022 (Unaudited) December 31, 2021 September 30, 2022 (Unaudited) December 31, 2021 ASSETS TOTAL ASSETS $ – $ – LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable and accrued liabilities $ - $ 1,139 Advances payable 49,652 19,659 Convertible notes payable - 210,000 TOTAL LIABILITIES 49,652 230,798 STOCKHOLDERS’ DEFICIT Preferred stock, par value .001 ; 10,000,000 shares authorized of which 10,000,000 are issued and outstanding 10,000 10,000 Common stock, par value .001 ; 300,000,000 shares authorized of which 18,010,208 shares are issued and outstanding 18,010 18,010 Additional paid in capital 274,639 35,195 Accumulated deficit ( 352,301 ) ( 294,003 ) TOTAL STOCKHOLDERS’ DEFICIT ( 49,652 ) ( 230,798 ) TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ – $ – The accompanying notes are an integral part of these unaudited condensed financial statements. 4 MDWERKS, INC, Condensed Statements of Operations September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Unaudited Unaudited For the Three Months Ended For the Nine Months Ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Operating expenses General and administrative 49,652 10,913 58,298 18,676 Total operating expenses 49,652 10,913 58,298 18,676 Net loss from operations ( 49,652 ) ( 10,913 ) ( 58,298 ) ( 18,676 ) Other income Gain on forgiveness of debt - - - 65,599 Total other income - - - 65,599 Net (loss) income $ ( 49,652 ) $ ( 10,913 ) $ ( 58,298 ) $ 46,923 Net (loss) income per share Basic $ ( 0.00 ) $ ( 0.00 ) $ ( 0.00 ) $ 0.00 Diluted $ ( 0.00 ) $ ( 0.00 ) $ ( 0.00 ) $ 0.00 WEIGHTED AVERAGE NUMBER OF SHARES Basic 18,010,208 18,010,208 18,010,208 18,010,208 Diluted 18,010,208 18,010,208 18,010,208 18,010,208 The accompanying notes are an integral part of these unaudited condensed financial statements. 5 MDWERKS, INC. CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT (Unaudited) Shares Amount Shares Amount Paid-in Capital Deficit Total Preferred Stock Common Stock Additional Accumulated Shares Amount Shares Amount Paid-in Capital Deficit Total Balance January 1, 2021 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 28,370 $ ( 331,979 ) $ ( 275,599 ) Net income (loss) - - - - - 46,923 46,923 Balance September 30, 2021 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 28,370 $ ( 285,056 ) $ ( 228,676 ) Balance July 1, 2021 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 28,370 $ ( 274,143 ) $ ( 217,763 ) Net income (loss) - - - - - ( 10,913 ) ( 10,913 ) Balance September 30, 2021 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 28,370 $ ( 285,056 ) $ ( 228,676 ) Balance January 1, 2022 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 35,195 $ ( 294,003 ) $ ( 230,798 ) Net income (loss) - - - - - ( 58,298 ) ( 58,298 ) Forgiveness of debt - - - - 239,444 - 239,444 Balance September 30, 2022 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 274,639 $ ( 352,301 ) $ ( 49,652 ) Balance July 1, 2022 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 35,195 $ ( 302,649 ) $ ( 239,444 ) Balance 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 35,195 $ ( 302,649 ) $ ( 239,444 ) Net income (loss) - - - - - ( 49,652 ) ( 49,652 ) Forgiveness of debt - - - - 239,444 - 239,444 Balance September 30, 2022 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 274,639 $ ( 352,301 ) $ ( 49,652 ) Balance 10,000,000 $ 10,000 18,010,208 $ 18,010 $ 274,639 $ ( 352,301 ) $ ( 49,652 ) The accompanying notes are an integral part of these unaudited condensed financial statements 6 MDWERKS, INC, Condensed Statements of Cash Flows (Unaudited) For the Nine months Ended September 30, 2022 (Unaudited) For the Nine months Ended September 30, 2021 CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) $ ( 58,298 ) $ 46,923 Adjustments to reconcile net loss to net cash used in operating activities: Gain on debt forgiveness – ( 65,599 ) Prepaid expenses – ( 23 ) Accounts payable ( 1,139 ) 93 NET CASH USED IN OPERATING ACTIVITIES ( 59,437 ) ( 18,606 ) CASH FLOWS FROM FINANCING ACTIVITIES: Advances payable 59,437 18,606 NET CASH PROVIDED BY FINANCING ACTIVITIES 59,437 18,606 NET INCREASE/(DECREASE) IN CASH – – CASH - BEGINNING OF PERIOD 0 0 CASH - END OF PERIOD 0 0 Supplemental disclosure of cash flow information: Cash paid for taxes $ – $ – Cash paid for interest $ – $ – Supplemental disclosure of non-cash investing and financing activities: Forgiveness of debt $ 239,444 $ – The accompanying notes are an integral part of these unaudited condensed financial statements. 7 MDWERKS, INC. Notes to Unaudited Condensed Financial Statements For the Nine months Ended September 30, 2022 (Unaudited) NOTE 1 – ORGANIZATION AND DESCRIPTION OF THE BUSINESS MDWerks, Inc. (the “Company”), a Delaware corporation, is focused on effecting a “reverse merger,” capital exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more unrelated businesses (the “Business Combination”) that would benefit from the Company’s public reporting status. The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. As of the date of this report, the Company had not yet commenced any operations. All activity through the date of this report relates to preserving cash, making settlements with creditors, attempting to raise capital, and continuing the Company’s public reporting. NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation – The financial statements present the financial position, results of operations and cash flows of the Company in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). All dollar amounts are rounded to the nearest thousand dollars. Cash and Cash Equivalents – The Company considers all highly liquid instruments with original maturities of three months or less when acquired, to be cash equivalents. The Company had no cash equivalents at September 30, 2022. Income Taxes – The Company complies with the accounting and reporting requirements of US GAAP in accounting for income taxes. The Company uses the asset and liability approach to financial reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in future taxable or deductible amounts and are based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred income tax assets to the amount expected to be realized. The Company also complies with US GAAP in accounting for uncertain tax positions. A tax benefit from an uncertain position may be recognized only if it is “more likely than not” that the position is sustainable based on its technical merits. Based on its analysis, the Company has determined that it has not incurred any liability for unrecognized tax benefits as of September 30, 2022. However, the Company’s conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, on-going analyses of and changes to tax laws, regulations and interpretations thereof. The Company recognizes interest and penalties related to unrecognized tax benefits in interest expense and other expenses, respectively. No interest expense or penalties have been recognized as of September 30, 2022. Earnings Per Share –Earnings per share is computed based on the weighted average number of common shares outstanding. Basic income (loss) per share excludes dilution and is computed by dividing income (loss) available to common stockholders by the weighted average common shares outstanding for the year. Diluted income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity. For the nine months ended September 30, 2022 there were no options, warrants or derivative securities outstanding. Therefore, basic and diluted loss per share were the same for the nine months ended September 30, 2022. Use of Estimates and Assumptions - The preparation of financial statements in accordance with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates. Fair Value of Financial Instruments - The Company measures its financial and non-financial assets and liabilities, as well as makes related disclosures, in accordance with FASB Accounting Standards Codification No. 820, Fair Value Measurement (“ASC 820”), which provides guidance with respect to valuation techniques to be utilized in the determination of fair value of assets and liabilities. Approaches include, (i) the market approach (comparable market prices), (ii) the income approach (present value of future income or cash flow), and (iii) the cost approach (cost to replace the service capacity of an asset or replacement cost). ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: 8 Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one more significant inputs or significant value drivers are unobservable. The carrying values of the Company’s accounts payable and accrued liabilities, advances payable, and convertible notes payable, approximate their fair value due to their short-term nature. Convertible notes payable - The Company accounts for convertible notes payable in accordance with the FASB Accounting Standards Codification No. 815, Derivatives and Hedging, since the conversion feature is not indexed to the Company’s stock and can’t be classified in equity. The Company allocates the proceeds received from convertible notes payable between the liability component and conversion feature component. The conversion feature that is considered embedded derivative liabilities has been recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company has also recorded the resulting discount on debt related to the conversion feature and is amortizing the discount using the effective interest rate method over the life of the debt instruments. Going Concern – These financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. As reflected in the accompanying financials, the Company had a net loss of $ 58,298 and an accumulated deficit of $ 352,301 as of and for the nine months ended September 30, 2022. Although management believes that it will be able to successfully execute a Business Combination, which includes third party financing and the raising of capital to meet the Company’s future liquidity needs, there can be no assurances in this regard. These matters raise substantial doubt about the Company’s ability to continue as a going concern. Recently Issued Accounting Pronouncements - From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“ FASB ”) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the effect of recently issued standards that are not yet effective will not have a material effect on its consolidated financial position or results of operations upon adoption. In August 2020, the FASB issued ASU 2020-06, “ Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40) ” (“ ASU 2020-06 ”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. The ASU is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU’s amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact of ASU 2020-06 on its financial statements. NOTE 3 – ACCOUNTS PAYABLE The Company had no accounts payable balance as of September 30, 2022 and $ 1,139 as of December 31, 2021 and related to amounts owed for various professional services and public company related expenses. 9 NOTE-4 ADVANCES PAYABLE The Company received advances aggregating $ 29,444 from a non-related 3 rd party through June 30, 2022 in order to cover legal, accounting and other various public company related operating expenses. The balance owed to this non-related party was $ 0 as of September 30, 2022. The Company received advances aggregating $ 49,652 from a non-related 3 rd party during the period ending September 30, 2022 in order to cover legal, accounting and other various public company related operating expenses. The balance owed to this non-related party was $ 49,652 as of September 30, 2022. The advances are unsecured, non-interest bearing and are due on demand. NOTE 5 – NOTES PAYABLE On July 18, 2014, the Company sold and issued a convertible promissory note in the principal amount of $ 210,000 to an investor in exchange for $ 210,000 in cash (the “Note”). The Note has no maturity date and is due on demand by the holder at any time. The Note converts into shares of the Company’s common stock at a fixed conversion price of $ 0.0005 per share provided that the Holder shall not convert into any amount exceeding 9.99 % of the then issued and outstanding shares of the Company. On July 28, 2020, the Note was subsequently sold and purchased by a non-related 3 rd party investor. The outstanding balance owed on this note is $ 0 and $ 210,000 as of September 30, 2022 and December 31, 2021, respectively. During July 2022, the holders of the Company’s shares of Preferred Stock sold their shares pursuant to a Stock Purchase Agreement (“SPA”), executed with (i) Tradition Reserve I LLC, a New York limited liability company (“Buyer”); and (ii) Ronin Equity Partners, Inc., a Texas corporation (“Seller”). The SPA, provides, among other things, that the Company’s obligations under its convertible notes and advances payable aggregating $ 239,444 are forgiven. The forgiveness of debt was recognized as capital contribution during July 2022 in the accompanying financial statements. NOTE 6 – CAPITAL STOCK The Company is authorized to issue 300,000,000 shares of Common stock, $ 0.001 par value, with such designations, rights and preferences as may be determined from time to time by the Board of Directors. The increase in authorized shares from 200,000,000 to 300,000,000 was effective September 13, 2022. At September 30, 2022, there were 18,010,208 shares issued and outstanding. Preferred stock The Company is authorized to issue 10,000,000 shares of preferred stock, $ .001 par value, with such designations, rights and preferences as may be determined from time to time by the Board of Directors, of which 10,000,000 shares are designated Series A Convertible Preferred. On June 15, 2014, the Company designated the Series A Convertible Preferred so that each share shall hold with its conversion rights of one hundred (100) shares of common stock for every share of Series A Preferred stock held, and that each share of Series A Preferred stock will also hold with it the same number of common share votes prior to conversion as it would if fully converted to be used in voting on any company matter requiring a vote of shareholders. At September 30, 2022, there were 10,000,000 shares issued and outstanding. NOTE 7 – CONTINGENCY In the ordinary course of business, the Company may become a party to lawsuits involving various matters. The impact and outcome of litigation, if any, is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company believes the ultimate resolution of any such current proceeding will not have a material adverse effect on our continued financial position, results of operations or cash flows. NOTE 8 – SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet and up to November 4, 2022, the date that the financial statements were issued. Based on the review, management has determined that there are no other items requiring disclosure or adjustment. 10 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Management’s Discussion and Analysis At September 30, 2022, the Company was not engaged in continued business. MDwerks, Inc., a Delaware corporation (“MDwerks”, the “Company, “we”, “us” or “our”) is a public shell company seeking to create value for its shareholders by merging with another entity with experienced management and opportunities for growth in return for shares of our common stock. No potential merger candidate has been identified at this time. We do not propose to restrict our search for a business opportunity to any industry or geographical area and may, therefore, engage in essentially any business in any industry. We have unrestricted discretion in seeking and participating in a business opportunity, subject to the availability of such opportunities, economic conditions, and other factors. The selection of a business opportunity in which to participate is complex and risky. Additionally, we have only limited resources and may find it difficult to locate good opportunities. There can be no assurance that we will be able to identify and acquire any business opportunity which will ultimately prove to be beneficial to us and our shareholders. We will select any potential business opportunity based on our management’s best business judgment. Capital Resources and Liquidity We believe that if we do not raise additional capital in the foreseeable future, we may be required to suspend or cease the implementation of our business plans. If we are unable to raise additional funds, there is substantial doubt as to our ability to continue as a going concern. We had no assets as of September 30, 2022 and December 31, 2021. We had liabilities aggregating $50,000 and $231,000 as of September 30, 2022 and December 31, 2021, respectively. We anticipate that our current cash and cash equivalents and cash generated from financing activities will be insufficient to satisfy our liquidity requirements for the next 12 months. To date, the Company has incurred an accumulated deficit of $352,000. The Company requires additional funding to meet its ongoing obligations and to fund anticipated operating losses. We believe that there is substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on raising capital to fund its initial business plan and ultimately to attain profitable operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty. We expect to incur marketing, professional, and administrative expenses as well expenses associated with maintaining our filings with the Commission. We will require additional funds during this time and will seek to raise the necessary additional capital. If we are unable to obtain additional financing, we may be required to reduce the scope of our business development activities, which could harm our business plans, financial condition and operating results. Additional funding may not be available on favorable terms, if at all. The Company intends to continue to fund its business by way of equity or debt financing and advances from related parties. Any inability to raise capital as needed would have a material adverse effect on our business, financial condition and results of operations. If we cannot raise additional funds, we will have to cease business operations. As a result, investors in the Company’s common stock would lose all of their investment. 11 Results of Operations Unaudited Operating Results For the Three Months Ended For the Nine Months Ended September 30, September 30, Increase/ (Decrease) Increase/ Decrease September 30, September 30, Increase/ (Decrease) Increase/ Decrease 2022 2021 $ % 2022 2021 $ % Operating expenses General and administrative 49,652 10,913 38,739 NM 58,298 18,676 39,622 212 % Total operating expenses 49,652 10,913 38,739 NM 58,298 18,676 39,622 212 % Net loss from operations (49,652 ) (10,913 ) (38,739 ) NM (58,298 ) (18,676 ) 39,622 212 % Other income Gain on forgiveness of debt - - - NM - 65,599 (65,599 ) -100 % Total other income - - - NM - 65,599 (65,599 ) -100 % Net income (loss) (49,652 ) (10,913 ) (38,739 ) NM (58,298 ) 46,923 (25,977 ) NM (NM): not meaningful At September 30, 2022, the Company was not engaged in continued business. There is minimal historical operational information about us on which to base an evaluation of our performance. Due to a lack of funding, we have not implemented our business operations. We cannot guarantee we will be successful in our business operations. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources, and possible delays in our planned product development. Our general and administrative expenses generally consists of professional fees. The increase in general and administrative expenses during the three and nine-month period ended September 30, 2022, when compared to the prior year periods, is primarily due to legal fees incurred in connection with our filings. During the nine-month period ended September 30, 2021, we recognized a gain on forgiveness of debt resulting from an agreement with one of our vendors. There were no similar agreements during the nine-month period ended September 30, 2022. Recent Developments On July 21, 2022, the Company in connection with the change of control and composition of the Board of Directors of the Company (the “Board”) entered into a Stock Purchase Agreement (the “SPA”) with (i) Tradition Reserve I LLC, a New York limited liability company (“Buyer”); and (ii) Ronin Equity Partners, Inc., a Texas corporation (“Seller”). 12 Pursuant to the SPA, the Seller agreed to sell, assign, transfer and deliver to the Buyer, on July 21, 2022 (the “Closing Date”) free and clear of all Liens, ten million (10,000,000) shares of Series A Convertible Preferred Stock, par value $0.001 (“Preferred Stock”) of the Company, held by the Seller (the “Shares”), representing 100% of the authorized and issued Preferred Stock, as of the Closing. In exchange for the sale, assignment, transfer and delivery of the Shares to Buyer, Buyer shall pay to the Seller a total purchase price of five hundred and twenty thousand ($520,000) Dollars (the “Purchase Price”). On July 21, 2022 (the “Closing Date”), the Purchase Price was paid in cash to the Seller pursuant to wire instructions provided to Buyer. Further, at the closing of the transactions contemplated within the SPA (which include, but are not limited to, the purchases and sales of the Shares described above) (the “Closing”), the parties agreed that as of the Closing: a) The Forgiven Debt (as defined hereinafter) was forgiven, as well as the Asia Note (as defined hereinafter), and any other loan agreements between the Company and Asia Pacific Partners, Inc. (“APP”), a Florida corporation. The Parties acknowledge and agreed that the Company was indebted to APP, an affiliate of the Seller, in the amount of approximately $239,444, comprised of (i) the principal amount and accrued interest pursuant to a convertible promissory note dated July 18, 2014 in the amount of $210,000 as originally issued by the Company to Azure Associates, Inc. and purchased by APP on July 28th, 2020 (the “Asia Note”), and (ii) various cash advances for a total of $29,444 as advanced by APP to the Company for working capital (the “Asia Cash Advances” and, together with any and all amounts that may have been due and payable pursuant to the Asia Note, the “Forgiven Debt”); b) The Company’s Board of Directors was required to undertake such actions as required to: (i) Expand the Company Board to be a number of persons as determined by Buyer, and to name such persons as selected by Buyer as directors on the Company Board; (ii) Name such persons as selected by Buyer as officers of the Company, to the positions as determined by Buyer; and (iii) Following (i) and (ii), all of the directors and officers of the Company, other than those named in or pursuant to (i) and (ii) shall resign from all such positions with the Company. The Closing was subject to certain customary closing conditions, including, but not limited to, the accuracy of the representations and warranties made by the parties, all necessary consents having been obtained to effect the transactions, and the r eceipt of any necessary government approvals in order to effect the transactions contemplated in the SPA. 13 The foregoing description of the SPA and the transactions contemplated pursuant to that SPA is qualified in its entirety by reference to the SPA, included as Exhibit 10.1 to the Current Report on Form 8-K filed on July 27, 2022 (“Current Report”). Prior to the Closing of the SPA, voting control of the Company was held by the Seller, of which Jacob D. Cohen was the primary shareholder, and held voting and dispositive control over the Shares. On the Closing Date, Buyer purchased the Shares, which both pre- and post-conversion represented approximately 98.23% of the Company’s outstanding voting securities as of the date of the Current Report, resulting in a change in control of the Company. The Company designated the Preferred Stock so that each share shall hold with it conversion rights of one hundred (100) shares of common stock for every share of Preferred stock held, and that each share of Preferred stock will also hold with it the same number of common share votes prior to conversion as it would if fully converted to be used in voting on any company matter requiring a vote of shareholders. At Closing Date, there were 18,010,208 shares of common stock issued and outstanding. Kerry Cassidy is the majority membership unit holder and Managing Member of the Buyer, and therefore is deemed to have voting and dispositive power over the Company’s Shares held by the Buyer. As a result of the Closing, the Company was no longer a company controlled by the Seller. Prior to the Closing, the Company was a shell company, and following the Closing, the Company continues to be a shell company. There has been no change in the Company’s shell company status or the Company’s operations as a result of the Closing. Off Balance Sheet Arrangements The Company has no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect or change on the company’s financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement, or other contractual arrangement to which an entity unconsolidated with the company is a party, under which the company has (i) any obligation arising under a guaranteed contract, derivative instrument or variable interest; or (ii) a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets. Item 3. Quantitative and Qualitative Disclosures About Market Risk. We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item. Item 4. Controls and Procedures. Disclosure Controls and Procedures Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is accumulated and communicated to management including our principal executive officer and principal financial officer as appropriate, to allow timely decisions regarding required disclosure. In connection with this quarterly report, as required by Rule 15d-15 under the Securities Exchange Act of 1934, we have carried out an evaluation of the effectiveness of the design and operation of our company’s disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our company’s management, including our company’s principal executive officer and principal financial officer. Based upon that evaluation, our company’s principal executive officer and principal financial officer concluded that subject to the inherent limitations noted in this Part II, Item 9A(T) as of September 30, 2022, our disclosure controls and procedures were not effective due to the existence of material weaknesses in our internal controls over financial reporting. Changes in Internal Control Over Financial Reporting There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f)) during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. 14 PART II—OTHER INFORMATION Item 1. Legal Proceedings. Currently we are not involved in any pending litigation or legal proceeding. Item 1A. Risk Factors. We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item. Item 2. Unregistered Sales of Securities and Use of Proceeds. None Item 3. Defaults Upon Senior Securities. None Item 4. Mine Safety Disclosure. None Item 5. Other Information. None Item 6. Exhibits Exhibit No. Descriptio n 31.1 Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act* 31.2 Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act* 32.1 Certification of Principal Executive Officer and of Principal Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act** 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith. ** Furnished herewith. 15 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MDWERKS, Inc. /s/ Steven C. Laker Steve Laker Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) November 4, 2022 16